Liuzhe Zhang
Overview
Explore the profile of Liuzhe Zhang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
33
Citations
93
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Zhang L, Iwata S, Saito M, Nakagawa M, Tsukushi S, Yoshida S, et al.
Clin Orthop Relat Res
. 2023 May;
481(12):2406-2416.
PMID: 37184605
Background: Reconstruction after periacetabular bone tumor resection involves important tradeoffs; large bone grafts or endoprostheses are reported to offer fair walking function in general but can be technically demanding and...
12.
Kobayashi H, Ito N, Nakai Y, Katoh H, Okajima K, Zhang L, et al.
Bone Joint J
. 2023 Apr;
105-B(5):568-574.
PMID: 37121579
The aim of this study was to report the patterns of symptoms and insufficiency fractures in patients with tumour-induced osteomalacia (TIO) to allow the early diagnosis of this rare condition....
13.
Zhang L, Akiyama T, Saito M, Okamoto M, Gokita T, Kobayashi H, et al.
Ann Surg Oncol
. 2023 Feb;
30(7):4475-4484.
PMID: 36853566
Background: Carbon ion radiotherapy (CIRT) is an evolving treatment option for malignant pelvic tumors in patients with poor surgical indications. However, the difference in complications and functional outcomes between CIRT...
14.
Zhang L, Akiyama T, Ohno T
Ann Surg Oncol
. 2023 Feb;
30(7):4485-4486.
PMID: 36853564
No abstract available.
15.
Miyamoto K, Kobayashi H, Zhang L, Tsuda Y, Makise N, Yasunaga Y, et al.
Case Rep Oncol
. 2023 Jan;
15(3):988-994.
PMID: 36636686
Atypical neurofibromatous neoplasm with unknown biological potential (ANNUBP), proposed in a recent NIH consensus overview, is a rare precursor entity of malignant peripheral nerve sheath tumor (MPNST) in neurofibromatosis type...
16.
Kobayashi H, Zhang L, Okajima K, Hirai T, Tsuda Y, Ikegami M, et al.
Jpn J Clin Oncol
. 2022 Dec;
53(2):138-145.
PMID: 36461784
Background: Primary tumor resection is the mainstay of treatment for malignant peripheral nerve sheath tumors. However, the efficacy of perioperative chemotherapy and radiotherapy for malignant peripheral nerve sheath tumors has...
17.
Kobayashi H, Makise N, Shinozaki-Ushiku A, Zhang L, Ishibashi Y, Ikegami M, et al.
Genes Chromosomes Cancer
. 2022 Jul;
62(1):47-51.
PMID: 35906852
Neurotropic tropomyosin receptor kinase (NTRK) gene rearrangements have been reported in limited cases of sarcomas; however, to date, there has been only one report of such rearrangements in malignant peripheral...
18.
Zhang L, Michihata N, Matsui H, Fushimi K, Yasunaga H, Tsuda Y, et al.
Jpn J Clin Oncol
. 2022 Jul;
52(10):1176-1182.
PMID: 35818346
Background: Massive intraoperative blood loss is common in pelvic malignant bone tumor surgery, and preoperative arterial embolization may be used in selected cases. Preoperative arterial embolization reportedly increases wound complications...
19.
Kobayashi H, Zhang L, Hirai T, Tsuda Y, Ikegami M, Tanaka S
Jpn J Clin Oncol
. 2022 Feb;
52(6):589-598.
PMID: 35184191
Background: Clinical characteristics of undifferentiated pleomorphic sarcoma of bone are not elucidated. Herein, we clarify its clinical features and analyze the efficacy of adjuvant chemotherapy in patients with undifferentiated pleomorphic...
20.
Kobayashi H, Zhang L, Hirai T, Tsuda Y, Ikegami M, Tanaka S
Int J Clin Oncol
. 2022 Jan;
27(4):802-810.
PMID: 35064354
Background: Primary tumor resection is the mainstay of treatment for undifferentiated pleomorphic sarcoma (UPS); however, the necessity of adjuvant chemotherapy has been debated. We aimed to clarify the effect of...